 Lack transmission live attenuated varicella vaccine virus immunocompromised children immunization siblings safety live attenuated Oka/Merck varicella vaccine well siblings children malignancy strategy risk household exposure immunocompromised children Susceptible children eligible vaccination child malignancy leukemia lymphoma solid tumor remission months evidence vaccine virus transmission children malignancy healthy susceptible siblings varicella vaccine Varicella-zoster virus oropharyngeal secretions vaccinees immunocompromised siblings None immunocompromised children vaccine-related rashes immunologic evidence subclinical varicella-zoster virus infection varicella-zoster virus IgG antibodies T-lymphocyte proliferation varicella-zoster virus healthy vaccinees cases varicella transmission high-risk sibling cases families immunocompromised children household exposure varicella months course immunosuppressive treatment